Diclofenac Sodium Tablet, Delayed Release
Product Images NDC 42291-231

3 FDA label images from Avkare · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 42291-231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 50mg

Label 50mg
Label for Diclofenac Sodium Delayed-Release Tablets USP 50 mg by AvKARE. The label indicates 180 tablets, prescription use only, with instructions to dispense with medication guide. It includes the NDC 42291-230-18 and barcode, along with storage and safety information.*
FDA Label Image

Label 75mg

Label 75mg
The label of AvKARE Diclofenac Sodium Delayed-Release Tablets USP shows a strength of 75 mg in a bottle containing 180 tablets. The label includes dispensing instructions for pharmacists and a barcode. The product is for oral use and prescription only.*
FDA Label Image

Dic05 0006 01

Dic05 0006 01
Chemical structure of Diclofenac Sodium, showing its molecular arrangement including two chlorinated aromatic rings and a carboxylate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.